Table 1 Clinicopathologic Characteristics of Patients
Characteristics | Â | No. of patients (N = 50) |
|---|---|---|
Age | Mean (range) | 60 years (33-77) |
Gender | Male: Female | 37 (74%): 13 (26%) |
Tumor type | Intrahepatic cholangiocarcinoma | 12 (24%) |
| Â | CBD cancer | 20 (40%) |
| Â | Ampulla of Vater cancer | 14 (28%) |
| Â | Gallbladder cancer | 4 (8%) |
Pathologic stage | Â | Â |
   Intrahepatic | I | 9 (18%) |
| Â | IIIC | 3 (6%) |
   Extrahepatic | IA | 3 (6%) |
| Â | IB | 10 (20%) |
| Â | IIA | 10 (20%) |
| Â | IIB | 14 (28%) |
| Â | III | 1 (2%) |
Tumor differentiation | Well differentiated | 8 (16%) |
| Â | Moderate differentiated | 34 (68%) |
| Â | Poorly differentiated | 4 (8%) |
| Â | Not classified | 4 (8%) |
Post-operative treatment | Observation | 22 (44%) |
| Â | Adjuvant chemotherapy | 3 (6%) |
| Â | Adjuvant chemoradiation | 25 (50%) |
Interval between post-operative treatment and suspicion of recurrence | Median (range) | 10.7 months (0.5-97.3) |
Interval between ceCT and PET/CT | Median (range) | 17 days (1-70) |